Antiaging Quantum Living Inc.
For the period ended Mar 31, 2025. Filed Jul 2, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Jul 2, 2025
AAQLStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets as of March 31, 2025 and 2024
ANTIAGING QUANTUM LIVING INC.
Consolidated Balance Sheets
As of March 31, 2025 and 2024
| March 31, | March 31, | |
|---|---|---|
| 2025 | 2024 | |
| ASSETS | ||
| Current Assets | ||
| Cash and cash equivalents | $370,549 | $166,552 |
| Accounts receivable, net | 85,788 | 2,001 |
| Advances to suppliers | 132,123 | 27,000 |
| Other receivables and current assets | 222,055 | 28,668 |
| Total Current Assets | 810,515 | 224,221 |
| Non-Current Assets | ||
| Property, plant and equipment, net | 120,769 | 215,770 |
| Intangible assets, net | 13,551 | - |
| Other non-current assets | - | 32,473 |
| Operating lease right of use asset, net | 644,515 | 539,946 |
| Total Non-Current Assets | 778,835 | 788,189 |
| Total Assets | 1,589,350 | 1,012,410 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||
| Current Liabilities | ||
| Accounts payable and accrued expenses | 50,244 | 64,842 |
| Other payables | 49,097 | 7,422 |
| Due to related parties | 520,000 | 613,843 |
| Taxes payable | 3,960 | 1,124 |
| Advances from customers | 8,475 | 4,345 |
| Operating lease liabilities - current portion | 46,050 | 179,872 |
| Total Current Liabilities | 677,826 | 871,448 |
| Non-Current Liabilities | ||
| Operating lease liabilities - non-current | 366,740 | 134,903 |
| Other long-term liabilities | - | 419,229 |
| Long term notes and loans payable-related party | 1,674,801 | - |
| Total Non-Current Liabilities | 2,041,541 | 554,132 |
| Total Liabilities | 2,719,367 | 1,425,580 |
| Commitments and Contingencies | - | - |
| Shareholders’ Equity | ||
| Class A Common stock, $0.00001 par value; 1,200,000,000 shares authorized, 29,995,000 shares issued and outstanding | 29,995 | 29,995 |
| Class B Common stock, $0.00001 par value; 1,200,000,000 shares authorized, no shares issued and outstanding | - | - |
| Class C Common stock, $0.00001 par value; 1,200,000,000 shares authorized, no shares issued and outstanding | - | - |
| Class D Common stock, $0.00001 par value; 1,200,000,000 shares authorized, no shares issued and outstanding | - | - |
| Class E Common stock, $0.00001 par value; 1,200,000,000 shares authorized, no shares issued and outstanding | - | - |
| Additional paid-in capital | 243,530 | 243,530 |
| Accumulated deficit | (1,409,712) | (689,303) |
| Accumulated other comprehensive income | 6,170 | 2,608 |
| Total Shareholders’ Deficit | (1,130,017) | (413,170) |
| Total Liabilities and Shareholders’ Deficit | $1,589,350 | $1,012,410 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.